Lucid Diagnostics (LUCD) Research & Development (2020 - 2026)

Lucid Diagnostics (LUCD) has 7 years of Research & Development data on file, last reported at $1.2 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 15.55% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $5.5 million (down 7.82% YoY), and the FY2025 full-year result was $5.7 million, down 5.24% from the prior year.
• Research & Development for Q1 2026 stood at $1.2 million, down from $1.7 million in the prior quarter.
• Across five years, Research & Development topped out at $3.4 million in Q2 2022 and bottomed at $1.2 million in Q1 2026.
• The 5-year median for Research & Development is $1.7 million (2024), against an average of $1.9 million.
• The widest annual swing landed in 2022, when Research & Development surged 83.66%; it then slumped 46.89% in 2023.
• A 5-year view of Research & Development shows it stood at $2.4 million in 2022, then fell by 21.46% to $1.9 million in 2023, then fell by 24.24% to $1.5 million in 2024, then rose by 18.58% to $1.7 million in 2025, then slumped by 30.01% to $1.2 million in 2026.
• The last three Research & Development figures came in at $1.2 million (Q1 2026), $1.7 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.

Peer Comparison